Zurück zu Projekte

25384.1 PFLS-LS

25384.1 PFLS-LS

Zusammenfassung

Identification of the most suitable drug candidate(s) of first selective endocannabinoid reuptake inhibitors (SERIs) for clinical development in neuropsychiatric disorders

Weitere Texte

Abstract

Selective endocannabinoid reuptake inhibitors (SERIs) are new chemical entities that modulate the endocannabinoid system with a potentially more effective and safer pharmacological profile as compared to other cannabinoid drugs. Preliminary analytical and behavioral pharmacology experiments indicate that SERIs are active in the central nervous system. The aim of this project relates to the identification of the best drug candidate(s) for clinical development and selection of the most suitable target indication(s) among neuropsychiatric disorders.

Beteiligte

Andrea Chicca

Kontaktperson

chicca@ibmm.unibe.ch

Universität Bern Institute of Biochemistry and Molec Andrea Chicca Bühlstrasse 28 3012 Bern BE CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2017-03-31
Enddatum
2019-05-31
Bewilligte Gesamtkosten
CHF 228997.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T115 Medical technology 100.0%